As society is bunkered down in self-isolation to prevent the spread of COVID-19, fintech company Novatti (ASX: NOV) has acquired payments platform Emersion with both businesses seeing a rise in online payment processing revenue to accommodate the new contact-free world. The acquisition will see Emersion integrated into Novatti, bringing with it the $1.7m in revenue
Read More
Highly publicised tragedies always seem to summon the most despicable of fraudsters. To the rage of many, we saw during the Australian bushfire disaster over 400 fundraiser scams being reported. It appears the coronavirus pandemic is no different, with stories of phishing emails, fraudulent calls and text messages, and even false claims of vaccine cures.
Read More
Australian medtech company ResApp (ASX: RAP) is set to make diagnosing sleep apnoea significantly easier for individuals with the launch of the SleepCheck smartphone app which has been clinically tested. Obstructive sleep apnoea (OSA) is one of the most common sleep breathing disorders which affects around 30%of men and 20%of women. However, studies show that
Read More
Despite trading on the ASX as a microcap, renewable energy company MPower (ASX: MPR) continues to execute a solid pipeline of construction contracts, today announcing the $4 million contract with Astronergy to build a 5MW solar farm in South Australia. The contract will see MPower execute the engineering, procurement and construction of the solar farm
Read More
Despite graphite being listed as a ‘critical mineral’ by global leaders, it is not currently produced in Australia. However, that could soon change with Archer Materials (ASX: AXE) confirming testing from its Campoona Prospect to be of the high quality required to produce coated spherical graphite for use in lithium-ion batteries. The testing was conducted
Read More
Australian medtech company Cyclopharm (ASX: CYC) is set to add the United States to the list of 59 countries which have approved Technegas®, its nuclear functional ventilation imaging agent, having lodged its New Drug Application (NDA) with the Food and Drug Administration (FDA). As the world’s largest nuclear medicine market in the world, the opportunity
Read More
Amidst the national lockdown to prevent the spread of COVID-19, the government has encouraged allied healthcare providers to remain open with many of these being essential community services capable of alleviating pressure from the public health system. In his national address on Tuesday night, it was emphasised by Prime Minister Scott Morrison that “health-related services
Read More
With containment of COVID-19 being our global priority for 2020, one of the key themes to have emerged from the pandemic is the collective encouragement by governments for their citizens to work from home (WFH) wherever possible. This has been integral in stopping the spread of coronavirus which can survive on surfaces for up to
Read More
Following last night’s national address by Prime Minister Scott Morrison, introducing an overseas travel ban, Virgin Australia (ASX: VAH) has made the difficult decision to ground 125 of its aircraft and stand down 80 per cent of its workforce. The move follows a similar one employed by Qantas (ASX: QAN) however, Virgin’s greater reliance on
Read More
Professional athletes may soon have a new treatment for knee osteoarthritis after Paradigm Biopharmaceuticals (ASX: PAR) received glowing endorsements from two former NFL players undergoing the current round of Zilosul® treatment trials. The trials of Zilosul® have been conducted on ten patients suffering from varying degrees of knee osteoarthritis under the Food and Drug Administration’s
Read More
